Combined Cryoablation and GM-CSF Treatment for Metastatic Hormone Refractory Prostate Cancer

Journal of Immunotherapy ◽

10.1097/cji.0b013e31818df785 ◽

2009 ◽

Vol 32 (1) ◽

pp. 86-91 ◽

Author(s):

Tongguo Si ◽

Zhi Guo ◽

Xishan Hao

Keyword(s):

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Gm Csf ◽

Hormone Refractory

Download Full-text

Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer

Cancer ◽

10.1002/cncr.23669 ◽

2008 ◽

Vol 113 (5) ◽

pp. 975-984 ◽

Author(s):

Celestia S. Higano ◽

John M. Corman ◽

David C. Smith ◽

Arthur S. Centeno ◽

Christopher P. Steidle ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Escalation ◽

Phase 1 ◽

Cellular Immunotherapy ◽

Hormone Refractory Prostate Cancer ◽

Dose Escalation Study ◽

Gm Csf ◽

Hormone Refractory

Download Full-text

1159. A Phase I/II Study of High Dose Allogeneic GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine in Patients with Metastatic Hormone-Refractory Prostate Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)41601-1 ◽

2003 ◽

Vol 7 (5) ◽

pp. S447 ◽

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

High Dose ◽

Hormone Refractory Prostate Cancer ◽

Gm Csf ◽

Hormone Refractory

Download Full-text

A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4565 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4565-4565 ◽

Author(s):

E. Small ◽

C. Higano ◽

D. Smith ◽

J. Corman ◽

A. Centeno ◽

...

Keyword(s):

Prostate Cancer ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

Hormone Refractory Prostate Cancer ◽

Phase 2 ◽

Gm Csf ◽

Phase 2 Study ◽

Hormone Refractory

Download Full-text

350. Phase II Trials of a GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine (GVAX) in Hormone Refractory Prostate Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)43180-1 ◽

2002 ◽

Vol 5 (5) ◽

pp. S116

Keyword(s):

Prostate Cancer ◽

Cell Line ◽

Cancer Cell ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

Hormone Refractory Prostate Cancer ◽

Phase Ii Trials ◽

Gm Csf ◽

Hormone Refractory

Download Full-text

Clinical and immunologic findings in a phase 2 study of a GM-CSF-secreting prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (met HPRC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.2517 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 2517-2517 ◽

Author(s):

J. W. Simons ◽

C. Higano ◽

D. Smith ◽

J. Corman ◽

C. Steidle ◽

...

Keyword(s):

Prostate Cancer ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

Hormone Refractory Prostate Cancer ◽

Phase 2 ◽

Gm Csf ◽

Phase 2 Study ◽

Hormone Refractory

Download Full-text

A Phase 2 Study of an Allogeneic GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine in Patients with Metastatic Hormone-Refractory Prostate Cancer

Journal of Immunotherapy ◽

10.1097/00002371-200411000-00117 ◽

2004 ◽

Vol 27 (6) ◽

pp. S32 ◽

Author(s):

Eric Small ◽

Celestia Higano ◽

David Smith ◽

Natalie Sacks ◽

Jonathan Simons

Keyword(s):

Prostate Cancer ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

Hormone Refractory Prostate Cancer ◽

Phase 2 ◽

Gm Csf ◽

Phase 2 Study ◽

Hormone Refractory

Download Full-text

A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4565 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4565-4565 ◽

Author(s):

E. Small ◽

C. Higano ◽

D. Smith ◽

J. Corman ◽

A. Centeno ◽

...

Keyword(s):

Prostate Cancer ◽

Cell Line ◽

Prostate Cancer Cell ◽

Cancer Cell Line ◽

Prostate Cancer Cell Line ◽

Hormone Refractory Prostate Cancer ◽

Phase 2 ◽

Gm Csf ◽

Phase 2 Study ◽

Hormone Refractory

Download Full-text

113 POSTER Phase II trial to assess the activity of MVA5T4 (Trovax®) alone versus MVA5T4 plus granulocyte macrophage colony-stimulating factor (GM-CSF) in patients (pts) with progressive hormone refractory prostate cancer (HRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)70119-7 ◽

2006 ◽

Vol 4 (12) ◽

pp. 38

Author(s):

R. Amato ◽

M. Karediy ◽

A. Cao ◽

M. Khan ◽

S. Naylor ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Colony Stimulating Factor ◽

Gm Csf ◽

Macrophage Colony Stimulating Factor ◽

Hormone Refractory ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

147: Low Concentration of a Histone Deacetylase Inhibitor, Depsipeptide (FK228), Enhances the Effect of Gemcitabine and Docetaxel in Hormone Refractory Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30412-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 50-51

Author(s):

Masatoshi Kanzaki ◽

Hideaki Kakinuma ◽

Teruaki Kumazawa ◽

Takamitsu Inoue ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cells ◽

Low Concentration ◽

Deacetylase Inhibitor ◽

Hormone Refractory

Download Full-text

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)30844-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 202-202

Author(s):

Hirotsugu Uemura ◽

Motoyoshi Tanaka ◽

Shigeya Uejima ◽

Takafumi Minami ◽

Kiyohide Fujimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text